News & Updates

While the mRNA vaccines currently available on the market have gained regulatory nods* for use in children aged 5 or 6 years old**, Moderna’s mRNA-1273 vaccine is setting a “new low” by showing that two 25 μg doses of the vaccine induce a robust immune response in infants/children as young as 6 months to <6 years of age, according to the latest data from the KidCOVE study.

Patients with metastatic adrenocortical carcinoma (ACC) derive benefit from cytoreductive surgery of the primary tumour by improving survival, reveals a recent study.

The presence of lymphovascular invasion (LVI) in patients with cutaneous squamous cell carcinoma is associated with higher rates of metastasis and death at 5 years, reveals a recent study, noting that future staging systems must incorporate LVI.

Recipients of left ventricular assist devices (LVADs) usually develop haemorrhagic events, which may lead to excess mortality, according to a recent study. While gastrointestinal (GI) bleeding is the most common, intracranial haemorrhages are most strongly associated with death.

Transcatheter aortic valve implantation (TAVI) with the SAPIEN 3 valve is a more cost-effective alternative to surgical aortic valve replacement (SAVR) in patients with severe symptomatic aortic stenosis who are at low risk of surgical mortality, a recent Italy study has found.

Despite being benign and causing only mild neurological impairments, spinal ependymoma makes it severely difficult for post-resection patients to return to their prior levels of professional and physical activities, a recent study has found.